e-Drug3D 824 |
cas 67-97-0 |
CLASS METABOLISM |
ROUTE (list) INTRAVENOUS ORAL |
PK parameters Tmax 10.6 HOUR Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET VITAMIN D3-25-HYDROXYLASE (25-OHASE) |
DrugCentral Vitamin D3 receptor UNIPROT P11473 VDR |
Download SDF file | (1S)-3-[2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Formula: Calculated chemical properties: MW 384.62 NB_atoms 28 XLogP 7.62 PSA 21.28 NB_HD 1 NB_HA 1 fsp3 0.78 Lipinski(0=no;1=yes) 0 |
FDA NDA 021163 (pdf not found) INN (CHOLECALCIFEROL) INFUVITE ADULT (SANDOZ CANADA INC) APPROVAL= AP YEAR= 2000 NDA 021265 (pdf not found) INN (CHOLECALCIFEROL) INFUVITE PEDIATRIC (SANDOZ CANADA INC) APPROVAL= AP YEAR= 2001 NDA 021559 (pdf not found) INN (CHOLECALCIFEROL) INFUVITE ADULT (SANDOZ INC) APPROVAL= AP YEAR= 2003 OBSOLETE NDA 021646 (pdf not found) INN (CHOLECALCIFEROL) INFUVITE PEDIATRIC PHARMACY BULK PACKAGE (SANDOZ INC) APPROVAL= AP YEAR= 2004 OBSOLETE NDA 021762 (pdf not found) INN (ALENDRONATE SODIUM ; CHOLECALCIFEROL) FOSAMAX PLUS D (ORGANON LLC) APPROVAL= AP YEAR= 2005 |
Other links: |